Skip to main content
logo
GE HealthCare Technologies Inc. (BMV:GEHC)
Mexico flag Mexico · Delayed Price · Currency is MXN
1,390.00
0.00 (0.00%)
Last updated: Feb 6, 2026, 8:30 AM CST

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Product Revenue
13.66B13.08B
Product Revenue Growth
4.48%-0.40%
Service Revenue
6.96B6.60B
Service Revenue Growth
5.56%2.68%
Revenue (Total)
20.63B19.67B
Revenue (Total) Growth
4.84%0.61%

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Imaging Revenue (Post-Q2 2024)
9.25B8.86B
Imaging Revenue (Post-Q2 2024) Growth
4.40%-1.00%
Advanced Visualization Solutions (AVS) Revenue
5.35B5.13B
Advanced Visualization Solutions (AVS) Revenue Growth
4.35%0.73%
Patient Care Solutions (PCS) Revenue
3.09B3.13B
Patient Care Solutions (PCS) Revenue Growth
-1.25%-0.54%
Pharmaceutical Diagnostics (PDx) Revenue
2.90B2.51B
Pharmaceutical Diagnostics (PDx) Revenue Growth
15.63%8.76%
Other Revenue
40.00M52.00M
Other Revenue Growth
-23.08%-21.21%
Revenue (Total)
20.63B19.67B
Revenue (Total) Growth
4.84%0.61%

Revenue Breakdown 3

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Patient Care Solutions (PCS) Revenue
3.09B3.13B
Patient Care Solutions (PCS) Revenue Growth
-1.25%-0.54%
Pharmaceutical Diagnostics (PDx) Revenue
2.90B2.51B
Pharmaceutical Diagnostics (PDx) Revenue Growth
15.63%8.76%
Other Revenue
40.00M52.00M
Other Revenue Growth
-23.08%-21.21%
Revenue (Total)
20.63B19.67B
Revenue (Total) Growth
4.84%0.61%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
USCAN Revenue
9.53B8.98B
USCAN Revenue Growth
6.12%5.03%
EMEA Revenue
5.43B5.05B
EMEA Revenue Growth
7.40%-0.14%
China Revenue
2.25B2.36B
China Revenue Growth
-4.62%-15.26%
Rest of World Revenue
3.42B3.28B
Rest of World Revenue Growth
4.21%3.86%
Revenue (Total)
20.63B19.67B
Revenue (Total) Growth
4.84%0.61%

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Imaging EBIT (Post-Q2 2024)
891.00M962.00M
Imaging EBIT (Post-Q2 2024) Growth
-7.38%17.17%
Advanced Visualization Solutions (AVS) EBIT
1.18B1.12B
Advanced Visualization Solutions (AVS) EBIT Growth
5.10%-0.53%
Patient Care Solutions (PCS) Segment EBIT
209.00M347.00M
Patient Care Solutions (PCS) Segment EBIT Growth
-39.77%-9.40%
Pharmaceutical Diagnostics (PDx) Segment EBIT
872.00M783.00M
Pharmaceutical Diagnostics (PDx) Segment EBIT Growth
11.37%26.90%
Other Segment EBIT
7.00M2.00M
Other Segment EBIT Growth
250.00%-81.82%
Operating Income (Other)
-391.00M-587.00M
Operating Income (Total)
2.76B2.63B
Operating Income (Total) Growth
5.26%7.80%

EBIT 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Patient Care Solutions (PCS) Segment EBIT
209.00M347.00M
Patient Care Solutions (PCS) Segment EBIT Growth
-39.77%-9.40%
Pharmaceutical Diagnostics (PDx) Segment EBIT
872.00M783.00M
Pharmaceutical Diagnostics (PDx) Segment EBIT Growth
11.37%26.90%
Other Segment EBIT
7.00M2.00M
Other Segment EBIT Growth
250.00%-81.82%
Operating Income (Total)
2.76B2.63B
Operating Income (Total) Growth
5.26%7.80%

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Products Remaining Performance Obligations (RPO)
5.00B4.76B
Products Remaining Performance Obligations (RPO) Growth
5.17%-3.55%
Services Remaining Performance Obligations (RPO)
10.73B9.74B
Services Remaining Performance Obligations (RPO) Growth
10.18%0.12%
Total Remaining Performance Obligations (RPO)
15.73B14.49B
Total Remaining Performance Obligations (RPO) Growth
8.54%-1.12%
Updated Dec 31, 2025. Data Source: Fiscal.ai.